Partnerships for Advancing Development of Diagnostics for Infectious Diseases
Forecasted Federal grant Posted
- Opportunity number
- RFA-AI-28-017
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications expected due
- Award size
- Not on record
Opportunity facts
- Expected posting
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- Public or Indian Housing Auth.
- 501(c)(3) Nonprofits
- City/Township Governments
- Non-501(c)(3) Nonprofits
- Higher Education Inst. (Private)
- Tribal Organizations (Not Federally Recognized)
- Higher Education Inst. (Public)
- Independent School Districts
- Small Businesses
- County Governments
- Special District Governments
- Tribal Governments (Federally Recognized)
- State Governments
- For Profit Organizations
- Other
- Points of contact
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) seeks applicants for Partnerships for Advancing Development of Diagnostics for Infectious Diseases, a cooperative agreement mechanism supporting translational development of infectious disease diagnostics with demonstrated proof-of-concept; this is a forecast with no application deadline specified.
NIAID requires partnerships between academic or small business investigators and one or more industrial partners. Eligible applicants include public or Indian housing authorities, 501(c)(3) nonprofits, city and township governments, non-501(c)(3) nonprofits, private and public higher education institutions, tribal organizations (federally and non-federally recognized), independent school districts, small businesses, county governments, special district governments, state governments, for-profit organizations, eligible federal agencies, U.S. territories or possessions, faith-based or community-based organizations, regional organizations, and non-domestic entities.
The program objective is to align early-stage diagnostic investigators with experienced industry partners to de-risk development and ensure commercial viability of diagnostic products needed to implement treatment strategies, evaluate vaccines, and identify infectious disease outbreaks. NIAID will establish a science advisory board for project oversight and facilitate annual meetings and workshops fostering collaboration among biotech and industry developers and other early diagnostic researchers.
No specific award ceiling, floor, or expected number of awards is stated in the forecast. The cooperative agreement structure provides flexibility for ongoing partner engagement and knowledge exchange throughout the performance period.
This opportunity is assigned to CFDA 93.855, Allergy and Infectious Diseases Research, administered by NIAID under the Department of Health and Human Services National Institutes of Health.
Forecast synopsis
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting partnerships between academic (or small business) investigators and one or more industrial partner(s) for translational development of a diagnostic test that has demonstrated proof-of-concept. Novel diagnostics are needed to implement treatment strategies, evaluate vaccines and identify infectious disease outbreaks, but too often, early diagnostic breakthroughs are not being translated into successful commercial products. Investigators often develop promising diagnostics but then face barriers when navigating the process towards commercialization. The goal is to align investigators with experienced industry partners early in the development process, to enable early de-risking and ensure that the end-product will be fit for purpose. A science advisory board together with NIAID oversight will help maintain the focus of projects. Annual meetings and workshops will foster collaborations and knowledge exchange with biotech/industry developers, and other investigators in the early diagnostic space. This partnership concept aligns with NIH's mission to support the translation of the most promising diagnostic technologies to better treat and prevent infectious diseases. Grant authorities that allow NIAID to forecast this opportunity are as follows: Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 2 CFR Part 200.
Eligibility
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity